CVE-2023-21923

CVE-2023-21923 is a high-severity vulnerability in Oracle Health Sciences Inform with a CVSS 3.x base score of 8.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Description

Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core). Supported versions that are affected are Prior to 6.3.1.3 and Prior to 7.0.0.1. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Health Sciences InForm. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Health Sciences InForm accessible data as well as unauthorized access to critical data or complete access to all Oracle Health Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Health Sciences InForm. CVSS 3.1 Base Score 8.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).

Frequently asked questions

What is CVE-2023-21923?
Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core). Supported versions that are affected are Prior to 6.3.1.3 and Prior to 7.0.0.1. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Health Sciences InForm. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Health Sciences InForm accessible data as well as unauthorized access to critical data or complete access to all Oracle Health Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Health Sciences InForm. CVSS 3.1 Base Score 8.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
How severe is CVE-2023-21923?
CVE-2023-21923 has a CVSS 3.x base score of 8.3, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability low.
Is CVE-2023-21923 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (44th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-21923?
CVE-2023-21923 primarily affects Oracle Health Sciences Inform. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-21923?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-21923 published?
CVE-2023-21923 was published on 2023-04-18 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Oracle Health Sciences Inform

All CVEs affecting Oracle Health Sciences Inform →

Other CWE-284 (Improper Access Control) vulnerabilities

Browse all CWE-284 (Improper Access Control) vulnerabilities →